Acadia Pharma (ACAD) Post Q3 Loss of $0.25/Share; Plans NUPLAZID NDA in Q1 2015
Go back to Acadia Pharma (ACAD) Post Q3 Loss of $0.25/Share; Plans NUPLAZID NDA in Q1 2015| Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) | Delayed: 22.60 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.60 | 52 Week High | $42.49 | |||
| Open | $22.60 | 52 Week Low | $16.64 | |||
| Day High | $22.60 | P/E | N/A | |||
| Day Low | $22.60 | EPS | $-0.42 | |||
| Volume | 112 | |||||
